Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19
The purpose of this study is to determine whether patients with COVID-19 improve faster if they receive plasma from those who have recovered from COVID-19, because it may have the ability to fight the virus that causes COVID-19.
Participants will receive plasma from a person who has recovered from COVID-19 with a compatible blood type.
- IRB Number: 2004191377
- Research Study Identifier: 2004191377